Showing posts with label Veterinary Therapeutics Market. Show all posts
Showing posts with label Veterinary Therapeutics Market. Show all posts

Tuesday, 13 November 2018

Veterinary Therapeutics Market - Kingdom Of Saudi Arabia Industry Analysis, Size, Share, Growth, Trends, And Forecast 2017 - 2025

Researchmoz added Most up-to-date research on "Veterinary Therapeutics Market - Kingdom Of Saudi Arabia Industry Analysis, Size, Share, Growth, Trends, And Forecast 2017 - 2025" to its huge collection of research reports.
This report on the KSA veterinary therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the KSA veterinary therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
Kingdom of Saudi Arabia Veterinary Therapeutics Market: Drivers and Restraints
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the KSA veterinary therapeutics market.
Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of product features of different types. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic animal and zoonotic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.


Kingdom of Saudi Arabia Veterinary Therapeutics Market: Segments
Based on product type, the KSA veterinary therapeutics market has been segmented into pharmaceuticals (ectoparasiticides, endoparasiticides, antibiotics, anti-inflammatories, and endectocides), vaccines (bacterial vaccines, and viral vaccines), nutritional feed additives (amino acids, vitamins, and minerals), and disinfectants (floor disinfectants, and disinfectants used in tissues). The market has been further studied from the point of view of major animal types. Based on animal type, the market has been categorized into companion animals and livestock animals.
This report provides in-depth analysis of the veterinary therapeutics market. The stakeholders for this report include pharmaceutical companies providing veterinary medicines. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition for different product type and animal type. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the KSA veterinary therapeutics market. Furthermore, the report incorporates market attractiveness analysis by product type and animal type that depicts the most attractive and significant segments in the KSA market in 2016.
Key Players Mentioned in this Report are:
The report also comprises list major global players in the market, their SWOT analysis, market share of these players in the veterinary therapeutics market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Dechra Animal Health, Elanco Animal Health, Merck Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis, Inc


The KSA veterinary therapeutics market has been segmented as follows:
KSA Veterinary Therapeutics Market, by Product Type
  • Pharmaceuticals
  • Ectoparasiticides
  • Endoparasiticides
  • Antibiotics
  • Anti-inflammatories
  • Endectocides
  • Vaccines
  • Bacterial
  • Viral
  • Nutritional Feed Additives
  • Amino Acids
  • Vitamins
  • Minerals
  • Disinfectants
  • Floor Disinfectants
  • Disinfectants Used in Tissues
KSA Veterinary Therapeutics Market, by Animal Type
  • Companion
  • Cats
  • Dogs
  • Livestock
  • Cattle
  • Sheep
  • Poultry

Wednesday, 25 October 2017

Veterinary Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Researchmoz added Most up-to-date research on "Veterinary Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" to its huge collection of research reports.

This report on the global veterinary therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global veterinary therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global veterinary therapeutics market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic animal and zoonotic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=842319

Based on product type, the global veterinary therapeutics market has been segmented into drugs (anti-infectives, anti-inflammatory, parasiticides, and others), vaccines (inactivated vaccines, live attenuated vaccines, recombinant vaccines, and others), and feed additives (amino acids, antibiotics, and others). The market has been further studied from the point of view of major animal types. Based on animal type, the market has been categorized into companion animals and livestock animals. On the basis of route of administration, the market has been segmented into oral, parenteral, and topical. Based on distribution channel, the market has been segmented into veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others.

Geographically, the global veterinary therapeutics market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Australia, South Africa, Brazil, and Mexico. The report also profiles major players in the veterinary therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Dechra Animal Health, Elanco Animal Health, Merck Animal Health, Merial Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis, Inc.

The global veterinary therapeutics market has been segmented as follows:

Global Veterinary Therapeutics Market, by Product Type
  • Drugs
  • Anti-infectives
  • Anti-inflammatory
  • Parasiticides
  • Others
  • Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Others
  • Medicated Feed Additives
  • Amino Acids
  • Antibiotics
  • Others
Global Veterinary Therapeutics Market, by Animal Type
  • Companion Animals
  • Livestock Animals
Global Veterinary Therapeutics Market, by Route of Administration
  • Oral
  • Parenteral
  • Topical
Global Veterinary Therapeutics Market, by Distribution Channel
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others
Global Veterinary Therapeutics Market, by Geography
  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific

Sunday, 11 June 2017

Rising Concern About The Use Of Antibiotics, Growth Promoters, Medical And Surgical Capabilities For Veterinary Therapeutics In Global Market From 2016 - 2024

ResearchMoz presents this most up-to-date research on "Rising Concern About The Use Of Antibiotics, Growth Promoters, Medical And Surgical Capabilities For Veterinary Therapeutics In Global Market From 2016 - 2024".

This report on the global veterinary therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global veterinary therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global veterinary therapeutics market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and growing number of acute and chronic animal and zoonotic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Based on product type, the global veterinary therapeutics market has been segmented into drugs (anti-infectives, anti-inflammatory, parasiticides, and others), vaccines (inactivated vaccines, live attenuated vaccines, recombinant vaccines, and others), and feed additives (amino acids, antibiotics, and others). The market has been further studied from the point of view of major animal types. Based on animal type, the market has been categorized into companion animals and livestock animals. On the basis of route of administration, the market has been segmented into oral, parenteral, and topical. Based on distribution channel, the market has been segmented into veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=842319

Geographically, the global veterinary therapeutics market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Australia, South Africa, Brazil, and Mexico. The report also profiles major players in the veterinary therapeutics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Dechra Animal Health, Elanco Animal Health, Merck Animal Health, Merial Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis, Inc.

The global veterinary therapeutics market has been segmented as follows:

Global Veterinary Therapeutics Market, by Product Type
  • Drugs
  • Anti-infectives
  • Anti-inflammatory
  • Parasiticides
  • Others
  • Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Others
  • Medicated Feed Additives
  • Amino Acids
  • Antibiotics
  • Others
Global Veterinary Therapeutics Market, by Animal Type
  • Companion Animals
  • Livestock Animals
Global Veterinary Therapeutics Market, by Route of Administration
  • Oral
  • Parenteral
  • Topical
Global Veterinary Therapeutics Market, by Distribution Channel
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others
Global Veterinary Therapeutics Market, by Geography
  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=842319